FEATURED COMPANIES
- LUPIN
- Mankind Pharma
- Perrigo
- Piramal Enterprises
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
About Emergency Contraceptive Pill
An emergency contraceptive pill is a short-term method of contraception that needs to be consumed within 72 hours of unprotected sexual intercourse, sexual assault, lapse in taking birth control pills, or condom breakage to prevent an unplanned pregnancy.
The analysts forecast the Global Emergency Contraceptive Pill Market to grow at a CAGR of 2.55% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the emergency contraceptive pill market. To calculate the market size, the report considers the revenue generated from the sales of emergency contraceptive pill.
The market is divided into the following segments based on geography:
Key vendors
An emergency contraceptive pill is a short-term method of contraception that needs to be consumed within 72 hours of unprotected sexual intercourse, sexual assault, lapse in taking birth control pills, or condom breakage to prevent an unplanned pregnancy.
The analysts forecast the Global Emergency Contraceptive Pill Market to grow at a CAGR of 2.55% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the emergency contraceptive pill market. To calculate the market size, the report considers the revenue generated from the sales of emergency contraceptive pill.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Key vendors
- LUPIN
- Mankind Pharma
- Perrigo
- Piramal Enterprises
- Sun Pharmaceutical Industries
- Rise in the number of initiatives to create awareness
- For a full, detailed list, view the full report
- Local governments limiting access to emergency contraceptive pills
- For a full, detailed list, view the full report
- Advent of online apps
- For a full, detailed list, view the full report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- LUPIN
- Mankind Pharma
- Perrigo
- Piramal Enterprises
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 09: REGIONAL LANDSCAPE
PART 11: DRIVERS AND CHALLENGES
Exhibit 01: Parent market
Exhibit 02: Global female contraceptive market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global emergency contraceptive pill 2017-2022 ($ mn)
Exhibit 09: Global emergency contraceptive pill market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global emergency contraceptive pill market by distribution channel – Market share 2017-2022 (%)
Exhibit 19: Comparison by distribution channel
Exhibit 20: Retail stores – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Retail stores – Year-over-year growth 2018-2022 (%)
Exhibit 22: Online stores – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Online stores – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by distribution channel
Exhibit 25: Customer landscape
Exhibit 26: Global emergency contraceptive pill market by geography – Market share 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top three countries in Americas
Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top three countries in EMEA
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top three countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: LUPIN overview
Exhibit 44: LUPIN – Business segments
Exhibit 45: LUPIN– Organizational developments
Exhibit 46: LUPIN– Geographic focus
Exhibit 47: LUPIN – Key offerings
Exhibit 48: Mankind Pharma overview
Exhibit 49: Mankind Pharma – Business segments
Exhibit 50: Mankind Pharma – Organizational developments
Exhibit 51: Mankind Pharma – Segment focus
Exhibit 52: Mankind Pharma – Key offerings
Exhibit 53: Perrigo overview
Exhibit 54: Perrigo– Business segments
Exhibit 55: Perrigo– Organizational developments
Exhibit 56: Perrigo– Geographic focus
Exhibit 57: Perrigo– Segment focus
Exhibit 58: Perrigo– Key offerings
Exhibit 59: Piramal Enterprises overview
Exhibit 60: Piramal Enterprises– Business segments
Exhibit 61: Piramal Enterprises– Organizational developments
Exhibit 62: Piramal Enterprises– Geographic focus
Exhibit 63: Piramal Enterprises– Segment focus
Exhibit 64: Piramal Enterprises– Key offerings
Exhibit 65: Sun Pharmaceutical Industries overview
Exhibit 66: Sun Pharmaceutical Industries– Business segments
Exhibit 67: Sun Pharmaceutical Industries– Organizational developments
Exhibit 68: Sun Pharmaceutical Industries– Geographic focus
Exhibit 69: Sun Pharmaceutical Industries– Segment focus
Exhibit 70: Sun Pharmaceutical Industries– Key offerings
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Segmentation by distribution channel
- Comparison by distribution channel
- Retail stores
- Online stores
- Market opportunity by distribution channel
PART 09: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas– Market size and forecast 2017-2022
- EMEA – Market size and forecast 2017-2022
- APAC – Market size and forecast 2017-2022
- Market opportunity
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Importance of family planning
- Advent of online apps
- Rising disposable income
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- LUPIN
- Mankind Pharma
- Perrigo
- Piramal Enterprises
- Sun Pharmaceutical Industries
- List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global female contraceptive market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global emergency contraceptive pill 2017-2022 ($ mn)
Exhibit 09: Global emergency contraceptive pill market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global emergency contraceptive pill market by distribution channel – Market share 2017-2022 (%)
Exhibit 19: Comparison by distribution channel
Exhibit 20: Retail stores – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Retail stores – Year-over-year growth 2018-2022 (%)
Exhibit 22: Online stores – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Online stores – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by distribution channel
Exhibit 25: Customer landscape
Exhibit 26: Global emergency contraceptive pill market by geography – Market share 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top three countries in Americas
Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top three countries in EMEA
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top three countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: LUPIN overview
Exhibit 44: LUPIN – Business segments
Exhibit 45: LUPIN– Organizational developments
Exhibit 46: LUPIN– Geographic focus
Exhibit 47: LUPIN – Key offerings
Exhibit 48: Mankind Pharma overview
Exhibit 49: Mankind Pharma – Business segments
Exhibit 50: Mankind Pharma – Organizational developments
Exhibit 51: Mankind Pharma – Segment focus
Exhibit 52: Mankind Pharma – Key offerings
Exhibit 53: Perrigo overview
Exhibit 54: Perrigo– Business segments
Exhibit 55: Perrigo– Organizational developments
Exhibit 56: Perrigo– Geographic focus
Exhibit 57: Perrigo– Segment focus
Exhibit 58: Perrigo– Key offerings
Exhibit 59: Piramal Enterprises overview
Exhibit 60: Piramal Enterprises– Business segments
Exhibit 61: Piramal Enterprises– Organizational developments
Exhibit 62: Piramal Enterprises– Geographic focus
Exhibit 63: Piramal Enterprises– Segment focus
Exhibit 64: Piramal Enterprises– Key offerings
Exhibit 65: Sun Pharmaceutical Industries overview
Exhibit 66: Sun Pharmaceutical Industries– Business segments
Exhibit 67: Sun Pharmaceutical Industries– Organizational developments
Exhibit 68: Sun Pharmaceutical Industries– Geographic focus
Exhibit 69: Sun Pharmaceutical Industries– Segment focus
Exhibit 70: Sun Pharmaceutical Industries– Key offerings
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- LUPIN
- Mankind Pharma
- Perrigo
- Piramal Enterprises
New Report Released: – Global Emergency Contraceptive Pill Market 2018-2022
The author of the report recognizes the following companies as the key players in the global emergency contraceptive pill market: LUPIN, Mankind Pharma, Perrigo, Piramal Enterprises, and Sun Pharmaceutical Industries.
Commenting on the report, an analyst from the research team said: “One trend affecting this market is the advent of online apps” The widespread use of emergency contraceptive pills worldwide, has led to the emergence of apps such as Lemonaid, Nurx, and Virtuwell that allow users to select the type and brand of emergency contraceptive pills by giving a variety of options.
According to the report, one driver influencing this market is the rise in the number of initiatives to create awareness. With the rise in the number of unplanned pregnancies worldwide, several governments and academic institutes are stepping in to promote the usage of contraception, including emergency contraceptive pills.
Further, the report states that one challenge affecting this market is the local governments limiting access to emergency contraceptive pills. Since the approval of the Plan B One-Step contraceptive pill by the FDA in 2013, that can be acquired without prescription or age restrictions, the use of the product has increased among teenagers. However, the distribution of such products is restricted on moral or ethical grounds.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The author of the report recognizes the following companies as the key players in the global emergency contraceptive pill market: LUPIN, Mankind Pharma, Perrigo, Piramal Enterprises, and Sun Pharmaceutical Industries.
Commenting on the report, an analyst from the research team said: “One trend affecting this market is the advent of online apps” The widespread use of emergency contraceptive pills worldwide, has led to the emergence of apps such as Lemonaid, Nurx, and Virtuwell that allow users to select the type and brand of emergency contraceptive pills by giving a variety of options.
According to the report, one driver influencing this market is the rise in the number of initiatives to create awareness. With the rise in the number of unplanned pregnancies worldwide, several governments and academic institutes are stepping in to promote the usage of contraception, including emergency contraceptive pills.
Further, the report states that one challenge affecting this market is the local governments limiting access to emergency contraceptive pills. Since the approval of the Plan B One-Step contraceptive pill by the FDA in 2013, that can be acquired without prescription or age restrictions, the use of the product has increased among teenagers. However, the distribution of such products is restricted on moral or ethical grounds.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- LUPIN
- Mankind Pharma
- Perrigo
- Piramal Enterprises
- Sun Pharmaceutical Industries
Note: Product cover images may vary from those shown
LOADING...
